One World Products, Inc. SEC filings OWPC
One World Products, Inc. has 187 filings in SEC EDGAR's recent list, going back to Nov 24, 2014. Its latest annual report, Form 10-K, was filed on Jun 3, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Jan 2, 2026, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| NT 10-Q | Filing | Nov 14, 2025 | Sep 30, 2025 |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | May 17, 2024 | Mar 31, 2024 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| NT 10-Q | Filing | Nov 15, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| RW | Filing | Jul 31, 2023 | — |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Apr 3, 2023 | Dec 31, 2022 |
| NT 10-Q | Filing | Aug 15, 2022 | Jun 30, 2022 |
| NT 10-K | Filing | Apr 1, 2022 | Dec 31, 2021 |
| NT 10-K | Filing | Apr 2, 2021 | Dec 31, 2020 |
| NT 10-Q | Filing | Nov 17, 2020 | Sep 30, 2020 |
| NT 10-K/A | Filing | May 15, 2020 | Dec 31, 2019 |
| NT 10-K | Filing | Mar 31, 2020 | Dec 31, 2019 |
| 8-A12G | Filing | Mar 3, 2020 | — |
| EFFECT | Filing | Oct 8, 2019 | — |
| CORRESP | Letter to the SEC | Oct 4, 2019 | — |
| CORRESP | Letter to the SEC | Oct 3, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2019 | — |
| D | Filing | Aug 23, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2019 | — |
| CORRESP | Letter to the SEC | Jul 12, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2019 | — |
| CORRESP | Letter to the SEC | Jun 28, 2019 | — |
| CORRESP | Letter to the SEC | Jun 13, 2019 | — |
| UPLOAD | Letter from the SEC | May 29, 2019 | — |
| NT 10-Q | Filing | May 16, 2019 | Mar 31, 2019 |
| UPLOAD | Letter from the SEC | Mar 7, 2019 | — |
| NT 10-Q | Notification of late filing | May 16, 2018 | Mar 31, 2018 |
| NT 10-K | Notification of late filing | Apr 2, 2018 | Dec 31, 2017 |
| NT 10-Q | Notification of late filing | Aug 15, 2017 | Jun 30, 2017 |
| NT 10-Q | Notification of late filing | May 19, 2017 | Mar 31, 2017 |
| NT 10-K | Notification of late filing | Mar 31, 2017 | Dec 31, 2016 |
| NT 10-Q | Notification of late filing | May 17, 2016 | Mar 31, 2016 |
| NT 10-K | Notification of late filing | Mar 31, 2016 | Dec 31, 2015 |
| SC 14F1 | Schedule 14f-1 | Jan 12, 2016 | — |
| EFFECT | Filing | May 28, 2015 | — |
| CORRESP | Letter to the SEC | May 27, 2015 | — |
| CORRESP | Letter to the SEC | May 15, 2015 | — |
| CORRESP | Letter to the SEC | Apr 17, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2015 | — |
| CORRESP | Letter to the SEC | Mar 19, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2015 | — |
| CORRESP | Letter to the SEC | Feb 18, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2015 | — |
| CORRESP | Letter to the SEC | Jan 9, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2014 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OWPC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Troy, MI
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1622244
- Former names
- One World Pharma, Inc. (until Nov 30, 2021); PUNTO GROUP, CORP. (until Jan 8, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.